The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Activation of the p62–Keap1–NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
Open accessAbstract
Ferroptosis is a recently recognized form of regulated cell death caused by an iron‐dependent accumulation of lipid reactive oxygen species. However, the molecular mechanisms regulating ferroptosis remain obscure. Here, we report that nuclear factor erythroid 2‐related factor 2 (NRF2) plays a central role in protecting hepatocellular carcinoma (HCC) cells against ferroptosis. Upon exposure to ferroptosis‐inducing compounds (e.g., erastin, sorafenib, and buthionine sulfoximine), p62 expression prevented NRF2 degradation and enhanced subsequent NRF2 nuclear accumulation through inactivation of Kelch‐like ECH‐associated protein 1. Additionally, nuclear NRF2 interacted with transcriptional coactivator small v‐maf avian musculoaponeurotic fibrosarcoma oncogene homolog proteins such as MafG and then activated transcription of quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1. Knockdown of p62, quinone oxidoreductase‐1, heme oxygenase‐1, and ferritin heavy chain‐1 by RNA interference in HCC cells promoted ferroptosis in response to erastin and sorafenib. Furthermore, genetic or pharmacologic inhibition of NRF2 expression/activity in HCC cells increased the anticancer activity of erastin and sorafenib in vitro and in tumor xenograft models. Conclusion: These findings demonstrate novel molecular mechanisms and signaling pathways of ferroptosis; the status of NRF2 is a key factor that determines the therapeutic response to ferroptosis‐targeted therapies in HCC cells. (H epatology 2016;63:173–184)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Phosphorylation of p62 initiates its interaction with E3 ligase KEAP1, therefore competing out alternate KEAP1 target Nrf2 and stabilizing Nrf2 signaling [102].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [102]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,974
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,001
Liu, F., Yang, Z., Li, J., Wu, T., Li, X., Zhao, L., Wang, W., Yu, W., Zhang, G., & Xu, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-01020-5 · Cited by 51
Yang, M., Cui, W., Lv, X., Xiong, G., Sun, C., Xuan, H., Ma, W., Cui, X., Cheng, Y., Han, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55785-8 · Cited by 50
Yang, H., Zhao, L., Gao, Y., Yao, F., Marti, T. M., Schmid, R. A., & Peng, R. (2020) · Cancers · doi:10.3390/cancers12113273 · Cited by 45
Wang, H., Peng, S., Cai, J., & Bao, S. (2021) · Cancer Management and Research · doi:10.2147/cmar.s278728 · Cited by 45
Salusin‑β participates in high glucose‑induced HK‑2 cell ferroptosis in a Nrf‑2‑dependent manner
Wang, W., Jiang, X., Gao, C.-C., & Chen, Z. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12313 · Cited by 46
The mechanisms and therapeutic targets of ferroptosis in cancer
Ye, L., Jin, F., Kumar, S. K., & Dai, Y. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.2011206 · Cited by 44
Bim- and Bax-mediated mitochondrial pathway dominates abivertinib-induced apoptosis and ferroptosis
Tang, Q., Chen, H., Mai, Z., Sun, H., Xu, L., Wu, G., Tu, Z., Cheng, X., Wang, X., & Chen, T. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.013 · Cited by 45
Ferroptosis and Its Emerging Role in Pre-Eclampsia
Chen, Z., Gan, J., Zhang, M., Du, Y., & Zhao, H. (2022) · Antioxidants · doi:10.3390/antiox11071282 · Cited by 46
Ferroptosis in non-alcoholic liver disease: Molecular mechanisms and therapeutic implications
Cheng, Z., Chu, H., Zhu, Q., & Yang, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1090338 · Cited by 45
Yu, K., Chen, Y., Zhang, L., Zheng, Y., Chen, J., Wang, Z., Yu, X., Song, K., Dong, Y., Xiong, F., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c07379 · Cited by 45
Impact of ferroptosis on preeclampsia: A review
Shan, Y., Guan, C., Wang, J., Qi, W., Chen, A., & Liu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115466 · Cited by 47
Fu, X., Han, H., Yang, H., Xu, B., Dai, W., Liu, L., He, T., Du, X., & Pei, X. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300138 · Cited by 45
Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis
Zhao, Y., Zhu, Q., Bu, X., Zhou, Y., Bai, D., Guo, Q., Gao, Y., & Lu, N. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101392 · Cited by 44
Zhang, C., Fortin, P., Barnoin, G., Qin, X., Wang, X., Álvarez, Á. F., Bijani, C., Maddelein, M., Hemmert, C., Cuvillier, O., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002992 · Cited by 46
Ferroptosis in cancer therapeutics: a materials chemistry perspective
Guan, Q., Zhou, L., & Dong, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01654g · Cited by 44
Xu, Y., Sang, W., Zhong, Y., Xue, S., Yang, M., Wang, C., Lu, H., Huan, R., Mao, X., Zhu, L., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13142 · Cited by 44
Molecular mechanisms of ferroptosis and its role in prostate cancer therapy
Wang, S., Wei, W., Ma, N., Qu, Y., & Liu, Q. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103732 · Cited by 44
Scuto, M. C., Salinaro, A. T., Caligiuri, I., Ontario, M. L., Greco, V., Sciuto, N., Crea, R., Calabrese, E. J., Rizzolio, F., Canzonieri, V., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111551 · Cited by 43
Cyclophosphamide Induces the Ferroptosis of Tumor Cells Through Heme Oxygenase-1
Shi, H., Hou, B., Li, H., Zhou, H., & Du, B. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.839464 · Cited by 47
Potential relationship between autophagy and ferroptosis in myocardial ischemia/reperfusion injury
Yang, Y., & Lin, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.012 · Cited by 44
Su, Y., Zhang, Z., Lee, L. T. O., Peng, L., Lu, L., He, X., & Zhang, X. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202663 · Cited by 43
Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy
Gu, X., Liu, Y., Dai, X., Yang, Y., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1137107 · Cited by 43
Shen, Y., Zhang, G., Wei, C., Zhao, P., Wang, Y., Li, M., & Sun, L. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01343 · Cited by 44
Yang, X., Jin, Y.-J., Ning, R., Mao, Q.-Y., Zhang, P., Zhou, L., Zhang, C.-C., Peng, Y.-C., & Chen, N. (2025) · Chinese Medicine · doi:10.1186/s13020-024-01047-0 · Cited by 48
Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis
Tan, S., Hou, X., & Mei, L. (2020) · Oncology Letters · doi:10.3892/ol.2020.11980 · Cited by 43
Kwon, O.-S., Kwon, E.-J., Kong, H., Choi, J., Kim, Y. J., Lee, E., Kim, W., Lee, H., & Cha, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101719 · Cited by 44
Cancer: The role of iron and ferroptosis
Rishi, G., Huang, G., & Subramaniam, V. N. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106094 · Cited by 43
Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells
Zhang, L., Zhang, J., Jin, Y., Yao, G., Zhao, H., Qiao, P., & Wu, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728172 · Cited by 45
Yan, B., Guo, J., Wang, Z., Ning, J., Wang, H., Shu, L., Hu, K., Chen, L., Shi, Y., Zhang, L., et al. (2023) · MedComm · doi:10.1002/mco2.337 · Cited by 41
Ferroptosis: a potential therapeutic target for stroke
Liu, C., Wang, G., Han, W., Tian, Q., & Li, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385284 · Cited by 44
Yang, X., Zheng, H., Niu, J., Chen, X., Li, H., Rao, Z., Guo, Y., Zhang, W., & Wang, Z. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116343 · Cited by 42
Li, Z., Zhang, Y. Z., Ji, M., Wu, C., Zhang, Y., & Ji, S.-L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116777 · Cited by 42
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer
Herrera-Abreu, M. T., Guan, J., Khalid, U., Ning, J., Costa, M. R., Chan, J., Li, Q., Fortin, J., Wong, W., Perampalam, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53837-7 · Cited by 51
Translating ferroptosis into oncology: challenges, opportunities and future directions
Kang, R., Liu, J., Wang, J., Kroemer, G., & Tang, D. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01128-z · Cited by 55
Self-citationYu, H., Wu, C., Wang, X., Ban, Q., Quan, C., Liu, M., Dong, H., Li, J., Kim, G., Choi, Y. H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1467-6 · Cited by 44
An Overview of the Ferroptosis Hallmarks in Friedreich’s Ataxia
Turchi, R., Faraonio, R., Lettieri‐Barbato, D., & Aquilano, K. (2020) · Biomolecules · doi:10.3390/biom10111489 · Cited by 42
The Regulatory Effects and the Signaling Pathways of Natural Bioactive Compounds on Ferroptosis
Zhang, S., Hu, R., Geng, Y., Chen, K., Wang, L., & Imam, M. U. (2021) · Foods · doi:10.3390/foods10122952 · Cited by 42
Wan, S., Lei, Y., Li, M., & Wu, B. (2021) · Hepatology International · doi:10.1007/s12072-021-10248-w · Cited by 41
Hussain, Y., Khan, H. Z., Alsharif, K. F., Khan, A. H., Aschner, M., & Saso, L. (2022) · Molecules · doi:10.3390/molecules27134145 · Cited by 41
The Regulation of Ferroptosis by Noncoding RNAs
Zheng, X., & Zhang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713336 · Cited by 45
SLC7A11: the Achilles heel of tumor?
Jiang, Y., & Sun, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1438807 · Cited by 41
Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer
Yang, B. C., & Leung, P. S. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.08.002 · Cited by 41
Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2
Fu, F., Lai, Q., Hu, J., Zhang, L., Zhu, X., Kou, J., Yu, B., & Li, F. (2022) · Antioxidants · doi:10.3390/antiox11030583 · Cited by 42
Entacapone alleviates acute kidney injury by inhibiting ferroptosis
Yang, J., Sun, X., Huang, N., Li, P., He, J., Jiang, L., Zhang, X., Han, S., & Xin, H. (2022) · The FASEB Journal · doi:10.1096/fj.202200241rr · Cited by 40
Self-citationLipid metabolism in ferroptosis and ferroptosis-based cancer therapy
Sun, Y., Xue, Z., Huang, T., Che, X., & Wu, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.941618 · Cited by 44
Ferroptosis: A New Development Trend in Periodontitis
Chen, K., Ma, S., Deng, J., Jiang, X., Ma, F., & Li, Z. (2022) · Cells · doi:10.3390/cells11213349 · Cited by 44
Mao, M., Wang, Z., Deng, B., Wang, Y., Zhou, D., Shen, L., Niku, W., & Zhang, N. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292124 · Cited by 40
Guo, M., Li, Y., Niu, S., Zhang, R., Shen, X., Ma, Y., Wu, L., Wu, T., Zhang, T., Tang, M., et al. (2024) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2024.104385 · Cited by 43
Ferroptosis and oxidative stress in endometriosis: A systematic review of the literature
Ni, C., & Li, D. (2024) · Medicine · doi:10.1097/md.0000000000037421 · Cited by 45
Current Progress of Ferroptosis Study in Hepatocellular Carcinoma
Zhu, X., Sha, X., Zang, Y., Ren, Q., Zhang, S., Ma, D., Wang, L., Yao, J., Zhou, X. Y., Yu, L., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.96014 · Cited by 41
Chan, F.-F., Kwan, K. K., Seoung, D.-H., Chin, D. W., Ng, I. O., Wong, C. C., & Wong, C. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.10.025 · Cited by 42
Liu, H., Zheng, S., Hou, G., Dai, J., Zhao, Y., Yang, F., Xiang, Z., Zhang, W., Wang, X., Gong, Y., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01414-2 · Cited by 40
Research mechanisms of and pharmaceutical treatments for ferroptosis in liver diseases
Yu, J. G., & Wang, J. (2020) · Biochimie · doi:10.1016/j.biochi.2020.11.002 · Cited by 39
Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management
Lou, J., Zhou, Y., Feng, Z., Ma, M., Yao, Y., Wang, Y., Deng, Y., & Wu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.616952 · Cited by 39
Gao, D., Huang, Y., Sun, X., Yang, J., Chen, J., & He, J. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17241 · Cited by 39
Self-citationMaterno-fetal iron transfer and the emerging role of ferroptosis pathways
Zaugg, J., Solenthaler, F., & Albrecht, C. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115141 · Cited by 40
Hao, X., Wang, H., Cui, F., Yang, Z., Liu, Y., Huang, R., & Meng, J. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01004-y · Cited by 40
Ferroptosis, a Rising Force against Renal Fibrosis
Liu, Y., & Wang, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7686956 · Cited by 40
Biological insights in non-small cell lung cancer
Rosell, R., Jain, A. S., Codony‐Servat, J., Lewintre, E. J., Morrison, B., Barretina, J., & González‐Cao, M. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0108 · Cited by 39
Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer
Din, M. A. U., Lin, Y., Wang, N., Wang, B., & Mao, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1383203 · Cited by 44
Lai, Y., Han, X., Xie, B., Xu, Y., Yang, Z., Wang, D., Li, W., Xie, Y., Song, W., Zhang, X., et al. (2024) · Cancer Science · doi:10.1111/cas.16186 · Cited by 39
Shen, Y., Zhao, M., Zhao, P., Meng, L., Zhang, Y., Zhang, G., Taishi, Y., & Sun, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1408462 · Cited by 45
The dual role of p62 in ferroptosis of glioblastoma according to p53 status
Yuan, F., Sun, Q., Zhang, S., Ye, L., Xu, Y., Deng, G., Xu, Z., Zhang, S., Liu, B., & Chen, Q. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00764-z · Cited by 39
Jiang, Z., Sun, H., Miao, J., Sheng, Q., Xu, J. F., Gao, Z., Zhang, X., Song, Y., & Chen, K. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.014 · Cited by 40
The Emerging Role of Heat Shock Factor 1 (HSF1) and Heat Shock Proteins (HSPs) in Ferroptosis
Aolymat, I., Hatmal, M. M., & Olaimat, A. N. (2023) · Pathophysiology · doi:10.3390/pathophysiology30010007 · Cited by 39
Ferroptosis in tumors and its relationship to other programmed cell death: role of non-coding RNAs
Zhang, Q., Fan, X., Zhang, X., & Ju, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04370-6 · Cited by 39
Bao, J., Wang, Z., Yang, Y., Yu, X., Yuan, W., Sun, W., & Chen, L. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13898 · Cited by 38
Li, Z., de Fromentel, C. C., Kim, W., Wang, W., Sun, J., Yan, B., Utturkar, S. M., Lanman, N. A., Elzey, B. D., Yeo, Y., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06302-0 · Cited by 38
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway
Ji, J., Cheng, Z., Zhang, J., Wu, J., Xu, X., Guo, C., & Feng, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18335 · Cited by 38
Hu, J., Zhu, J., Wang, K., Yan, X., Xu, L., Zhang, X., Ding, H., Yang, P., Hu, S., & Xie, R. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202405383 · Cited by 38
Nguyen, T. H. P., Mahalakshmi, B., & Velmurugan, B. K. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108930 · Cited by 37
Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases
Le, Y., Zhang, Z., Wang, C., & Lu, D. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200731175328 · Cited by 41
Ferroptosis-Related Genes in Neurodevelopment and Central Nervous System
Kim, S.-W., Kim, S.-W., Kim, Y.-J., & An, J. (2021) · Biology · doi:10.3390/biology10010035 · Cited by 40
Wang, S., Cao, K., Liao, Y. A., Zhang, W., Zheng, J., Li, X., Huang, M., Zhong, Y., Hu, X., Chen, D., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01855-w · Cited by 38
Self-citationAtractylodin may induce ferroptosis of human hepatocellular carcinoma cells
He, Y., Fang, D., Liang, T., Pang, H., Nong, Y., Tang, L.-B., Yang, Z., Lu, C., Han, X., Zhao, S., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4386 · Cited by 38
Wang, Y., Zhao, S., Jia, N., Shen, Z., Huang, D., Wang, X., Wu, Y., Pei, C., Shi, S., He, Y., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7606 · Cited by 38
Ma, T., Zhou, Y., Wang, C., Wang, L., Chen, J., Yang, H., Zhang, C.-Y., Zhou, Y., & Guan, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1098970 · Cited by 62
The role of ferroptosis in fish inflammation
Gao, F., Shi, X., Pei, C., Zhao, X., Zhu, L., Zhang, J., Li, L., Li, C., & Kong, X. (2022) · Reviews in Aquaculture · doi:10.1111/raq.12719 · Cited by 38
Iron as a therapeutic target in chronic liver disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.616 · Cited by 42
Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy
Zhang, Y., Zhang, Y., Tao, H., Zhu, J., Lu, Y., Cheng, F., Xiong, Y., Liu, J., Cai, G., Zhang, Z., et al. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216405 · Cited by 37
Sun, K., Zhi, Y., Ren, W., Li, S., Zhou, X., Gao, L., & Zhi, K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115892 · Cited by 37
Fisetin suppresses ferroptosis through Nrf2 and attenuates intervertebral disc degeneration in rats
Li, C., Zhang, Y., Deng, Y., Chen, Y., Wu, C., Zhao, X., Chen, X., Wang, X., Zhou, Y., Zhang, X., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176298 · Cited by 37
Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies
Vahidinia, Z., Tameh, A. A., Barati, S., Izadpanah, M., & Hosseini, E. S. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00551-3 · Cited by 37
Ferroptosis: Biology and Role in Gastrointestinal Disease
Escuder‐Rodríguez, J.-J., Liang, D., Jiang, X., & Sinicrope, F. A. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.051 · Cited by 41
Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs
Yin, J., Xu, X., Guo, Y., Sun, C., Yang, Y., Liu, H., Yu, P., Wu, T. S., & Song, X. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02181-2 · Cited by 42
NFE2L2 and ferroptosis resistance in cancer therapy
Tang, D., & Kang, R. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.123 · Cited by 41
Self-citationTackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer
Hao, Q., Gan, Y., & Zhou, X. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01387-x · Cited by 43
Xie, X., He, J.-T., Wang, Z., Xiao, H.-Q., Zhou, W., Du, S., Xue, Y., & Wang, Q. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.03.015 · Cited by 37
Mylka, V., Deckers, J., Ratman, D., Cauwer, L. D., Thommis, J., Rycke, R. M. D., Impens, F., Libert, C., Tavernier, J. H., Berghe, W. V., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1495681 · Cited by 35
Multifaceted roles of HSF1 in cell death: A state-of-the-art review
Zhang, B., Fan, Y., Cao, P., & Tan, K. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188591 · Cited by 37
Tetramethyl bisphenol a inhibits leydig cell function in late puberty by inducing ferroptosis
Hu, D., Tian, L., Li, X., Chen, Y., Xu, Z., Ge, R., & Wang, Y. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113515 · Cited by 37
Therapeutic Implications of Ferroptosis in Renal Fibrosis
Zhang, Y., Mou, Y., Zhang, J., Suo, C., Zhou, H., Gu, M. J., Wang, Z., & Tan, R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.890766 · Cited by 38
Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease
Lane, D. J. R., Alves, F. M., Ayton, S., & Bush, A. I. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0318 · Cited by 36
Chen, F., Zhan, J., Liu, M., Mamun, A. A., Huang, S., Tao, Y., Zhao, J., Zhang, Y., Xu, Y., He, Z., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85692 · Cited by 36
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy
Jalali-Zefrei, F., Shormij, M., Dastranj, L., Alvandi, M., Shaghaghi, Z., Farzipour, S., & Polgardani, N. Z. (2023) · Current Radiopharmaceuticals · doi:10.2174/0118744710262369231110065230 · Cited by 39
Zhou, D., Lu, P., Mo, X., Yang, B., Chen, T., Yao, Y., Xiong, T., Lin, Y., & Yang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1248934 · Cited by 38
GAS41 modulates ferroptosis by anchoring NRF2 on chromatin
Wang, Z., Yang, X. P., Chen, D., Liu, Y., Li, Z., Duan, S., Zhang, Z., Jiang, X., Stockwell, B. R., & Gu, W. J. (2024) · Nature Communications · doi:10.1038/s41467-024-46857-w · Cited by 38
Self-citationLi, X., Xu, H., Zhao, X., Li, Y., Lv, S., Zhou, W. J., Wang, J., Sun, Z., Li, Y., & Guo, C. (2024) · Particle and Fibre Toxicology · doi:10.1186/s12989-024-00579-5 · Cited by 36
Ashoub, M. H., Razavi, R., Heydaryan, K., Salavati‐Niasari, M., & Amiri, M. (2024) · European journal of medical research · doi:10.1186/s40001-024-01822-7 · Cited by 37
The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma
Cai, H., Meng, Z., & Yu, F. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104361 · Cited by 37
Metadata
- Authors
- Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D.
- Affiliations
- Third Affiliated Hospital of Guangzhou Medical University (CN)
- University of Pittsburgh (US)
- Corresponding author
- Tang, Daolin
- Venue
- Hepatology
- Published
- 2015-11-26
- Volume
- 63
- Issue
- 1
- Pages
- 173-184
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- PMC
- PMC4688087
- OpenAlex
- W2163005196
- Cited by
- 2,012
- References
- 40
- Citations by year
- 2026: 165 · 2025: 255 · 2024: 311 · 2023: 309 · 2022: 342 · 2021: 255 · 2020: 165 · 2019: 92 · 2018: 52 · 2017: 30 · 2016: 26 · 2015: 2
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-08-01)
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- University of Pittsburgh
- National Natural Science Foundation of China (201508020258, R01GM115366, 201400000003, R01CA160417, 81502445, 31171229, U1132005)
- National Institutes of Health (R01GM115366 to D.T.)
- National Cancer Institute (R01CA160417)
- National Institute of General Medical Sciences (R01GM115366)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- ferroptosis, Nrf2, p62, Keap1, hepatocellular carcinoma, erastin, sorafenib, buthionine sulfoximine, quinone oxidoreductase 1, heme oxygenase-1, FTH1, MAFG, ferroptosis-targeted therapy, iron-dependent lipid peroxidation
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Carcinoma, Hepatocellular, Humans, Iron, Liver Neoplasms, Mice, Inbred C57BL, Tumor Cells, Cultured, Signal Transduction, RNA-Binding Proteins, Cell Death, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review